An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England: A Policy Modeling Study

被引:73
|
作者
Collins, Marissa [1 ]
Mason, Helen [1 ]
O'Flaherty, Martin [2 ]
Guzman-Castillo, Maria [2 ]
Critchley, Julia [3 ]
Capewell, Simon [2 ]
机构
[1] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland
[2] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England
[3] Univ London, Div Populat Hlth Sci & Educ PHSE St Georges, London, England
基金
英国医学研究理事会;
关键词
cardiovascular disease; economic evaluation; population health; salt; UK policy; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; CASE-FATALITY; PREVENTION; TRENDS; WALES;
D O I
10.1016/j.jval.2014.03.1722
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Dietary salt intake has been causally linked to high blood pressure and increased risk of cardiovascular events. Cardiovascular disease causes approximately 35% of total UK deaths, at an estimated annual cost of 30 billion. The World Health Organization and the National Institute for Health and Care Excellence have recommended a reduction in the intake of salt in people's diets. This study evaluated the cost-effectiveness of four population health policies to reduce dietary salt intake on an English population to prevent coronary heart disease (CHD). Methods: The validated IMPACT CHD model was used to quantify and compare four policies: 1) Change4Life health promotion campaign, 2) front-of-pack traffic light labeling to display salt content, 3) Food Standards Agency working with the food industry to reduce salt (voluntary), and 4) mandatory reformulation to reduce salt in processed foods. The effectiveness of these policies in reducing salt intake, and hence blood pressure, was determined by systematic literature review. The model calculated the reduction in mortality associated with each policy, quantified as life-years gained over 10 years. Policy costs were calculated using evidence from published sources. Health care costs for specific CHD patient groups were estimated. Costs were compared against a "do nothing" baseline. Results: All policies resulted in a life-year gain over the baseline. Change4life and labeling each gained approximately 1960 life-years, voluntary reformulation 14,560 life-years, and mandatory reformulation 19,320 life-years. Each policy appeared cost saving, with mandatory reformulation offering the largest cost saving, more than 660 million. Conclusions: All policies to reduce dietary salt intake could gain life years and reduce health care expenditure on coronary heart disease.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 50 条
  • [31] Clinical and Economic Evaluation of Salvianolate Injection for Coronary Heart Disease: A Retrospective Study Based on National Health Insurance Data in China
    Yang, Lisong
    Chen, Xiaolan
    Ung, Carolina Oi Lam
    Zhu, He
    Hu, Hao
    Han, Sheng
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [32] LONGITUDINAL-STUDY OF CORONARY HEART-DISEASE RISK FACTOR REDUCTION IN THE WORKPLACE
    LEIGH, J
    COMMUNITY HEALTH STUDIES, 1988, 12 (04): : 479 - 480
  • [33] An appropriate use criterion is very important to reduce overuse for SPECT in coronary heart disease: Economic burden in time of crises
    Dominguez-Rodriguez, Alberto
    Angeles Gomez, Maria
    del Carmen Garcia-Baute, Maria
    Abreu-Gonzalez, Pedro
    Gonzalez-Diaz, Antonieta
    Laynez-Cerdena, Ignacio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 4516 - 4517
  • [34] RISK OF CORONARY HEART DISEASE IN PATIENTS WITH CHRONIC RENAL FAILURE - EVALUATION STUDY
    Patiakas, S.
    Charalampous, C.
    Basiliou, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 167 - 167
  • [35] Population Reductions in Coronary Heart Disease Associated with Modest Decreases in Salt Intake: Projections from the CHD Policy Model
    Bibbins-Domingo, Kirsten
    Chertow, Glenn
    Moran, Andrew
    Coxson, Pamela
    Goldman, Lee
    CIRCULATION, 2009, 119 (10) : E294 - E294
  • [36] Health-Economic Evaluation of a Disease Management Program for Chronic Heart Failure in Austria - A Decision-Analytic Modeling Study
    Jahn, Beate
    Puntscher, Sibylle
    Santamaria, Julia
    Muehlberger, Nikolai
    Scroczynski, Gaby
    Rochau, Ursula
    Siebert, Silke
    Arvandi, Marjan
    Moertl, Deddo
    Pfoertner, Sylvia Reitter
    Kiss, Noemi
    Hochwallner, Christina
    Walter, Evelyn
    Thokala, Praveen
    Gohler, Alexander
    Siebert, Uwe
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP63 - NP64
  • [37] Population-based health-economic evaluation of the secondary prevention of coronary heart disease in Finland
    Soini, Erkki J. O.
    Davies, Glenn
    Martikainen, Janne A.
    Hu, Henry X.
    Tunceli, Kaan
    Niskanen, Leo
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (01) : 25 - 36
  • [38] Economic evaluation of Cardio inCode®, a clinical-genetic function for coronary heart disease risk assessment
    Ramírez De Arellano A.
    Coca A.
    De La Figuera M.
    Rubio-Terrés C.
    Rubio-Rodríguez D.
    Gracia A.
    Boldeanu A.
    Puig-Gilberte J.
    Salas E.
    Applied Health Economics and Health Policy, 2013, 11 (5) : 531 - 542
  • [39] Policy-makers' attitudes to decision support models for coronary heart disease: a qualitative study
    Taylor-Robinson, David
    Milton, Beth
    Lloyd-Williams, Ffion
    O'Flaherty, Martin
    Capewell, Simon
    JOURNAL OF HEALTH SERVICES RESEARCH & POLICY, 2008, 13 (04) : 209 - 214
  • [40] Evaluation of population impact of candidate polymorphisms for coronary heart disease in the Framingham Heart Study Offspring Cohort
    Yu Yan
    Yijuan Hu
    Kari E North
    Nora Franceschini
    Danyu Lin
    BMC Proceedings, 3 (Suppl 7)